Boston Scientific Corporation
Boston Scientific shares weakened after quarterly results and CHAMPION-AF data failed to provide the positive catalyst investors had hoped for. U.S. Electrophysiology and…
TCW Concentrated Large Cap Growth Fund invests primarily in a concentrated portfolio of large-capitalisation growth companies. The managers combine secular growth themes such as AI infrastructure with company-specific fundamental analysis and maintain a balanced portfolio across offensive and defensive growth exposures.
Boston Scientific shares weakened after quarterly results and CHAMPION-AF data failed to provide the positive catalyst investors had hoped for. U.S. Electrophysiology and…
Intuitive Surgical reported revenue and Da Vinci procedure growth above consensus while also raising 2026 guidance. TCW believes the company remains early in the Da Vinci 5…
TCW purchased Micron as a direct beneficiary of the AI infrastructure buildout, which is turning memory from a commodity component into a mission-critical strategic asset. The…
CrowdStrike produced strong quarterly results including 32% year-on-year growth in net new ARR, improving operating margins and 67% growth in free cash flow. Management raised…
Palo Alto Networks delivered strong quarterly results with accelerating organic growth, better-than-planned CyberArk integration and guidance above consensus expectations. TCW…
TCW purchased KLA because increasing semiconductor complexity is driving greater demand for advanced inspection, review and metrology systems across chip fabrication. The fund is…
Source PDFs are not republished here; only extracted ideas and quotes.